Dr Gould covered the risks of co-prescribing benzodiazepines and opioids, particularly for elderly patients, and proposed therapeutic alternatives at PAINWeek 2017.
Jennifer Bolen, JD, provides PAINWeek 2017 attendees with information on risk reduction and response to medication overdose events.
Mental disorders and psychotropic medication use are associated with an increased risk for fracture but are not fully captured by a tool used to assess fracture risk in the general population.
Clobazam is more effective than placebo in reducing low back pain.
Throughout 2016, the FDA has announced requirements for manufacturers to create new product labeling information for a variety of opioid medications.
Meta-analysis shows muscle relaxants are effective in reducing acute but not chronic low back pain.
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioids Might Not Be the Answer to the Opioid Crisis
- Paracetamol Superior to Placebo for Osteoarthritis Knee Pain
- Fracture Risk in Children Predicted by New Bone Density Assessment
- Collaborative Care Superior to Standard Care for Opioid Use Disorder
- Gabapentinoids: Evaluating the Benefits for Chronic Low Back Pain